January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties. Our goal is to create novel drugs with superior efficacy and reduced toxicity in hard-to-treat malignancies with initial application in advanced pancreatic, lung, and ovarian cancers.
View Top Employees from January TherapeuticsWebsite | http://januarytx.com |
Employees | 3 (3 on RocketReach) |
Founded | 2017 |
Address | 11575 Sorrento Valley Rd, San Diego, California 92121, US |
Technologies |
JavaScript,
HTML,
Twitter
+6 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering, Clinical Trials, Health Care, Therapeutics |
Looking for a particular January Therapeutics employee's phone or email?
Curtis Monnig is the Vice President, Chemistry, Manufacturing and Controls of January Therapeutics.
3 people are employed at January Therapeutics.
January Therapeutics is based in San Diego, California.